FyoniBio

Biotechnology Research • Berlin, Berlin, Germany • 21-50 Employees

Company overview

Headquarters	Robert-Roessle-Str. 10, Berlin, Berlin 13125, DE
Phone number	+493094892500
Website	fyonibio.com
NAICS	541714
Keywords	Clinical Trials, Biosimilars, Mass Spectrometry, Formulation Development, Translational Research, Genotyping, Gclp, Central Laboratory, Research Support Services, Biomarker, Cell Line Development, Immunomonitoring, Bioprocess Optimization, Cell-Based Activity Assays, Assay Development And Validation, Bioanalytical Service, Biopharmaceutical Contract Development Service, Chonamite, Clinical Sample Analysis, Glycan Analytics, Glyco-Optimization, Glycoexpress, Pk And Immunogenicity Testing, Usp And Dsp Process Development
Founded	2021
Employees	21-50
Socials

Key Contacts at FyoniBio

Lars Stöckl

Managing Director / Geschäftsführer

Hans Baumeister

Managing Director

Lena Tholen

Director Cell Line And Bioprocess Development

Frederick Gyapon Quast

Director, Business Development

Berna Ustuner

Associate Director - Cell Line And Bioprocess Development

Robert Marius Wilmanowski

Director Instrumental Bioanalytics

Hülya Kaplan

Director Quality Management

FyoniBio Email Formats

FyoniBio uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@fyonibio.com), used 72.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@fyonibio.com	72.7%
{first initial}.{last name}	j.doe@fyonibio.com	27.3%

About FyoniBio

FyoniBio is a contract development organization and clinical laboratory offering smart and custom-tailored services at different drug development stages to pharmaceutical and biotechnology companies. Based on 20 years of experience, we provide ISO-9001:2015 fully-integrated services from cell line engineering over process development and drug quality control up to broad bioanalytical capabilities for preclinical and clinical studies. A special focus lies on drug glycosylation as this is a critical quality attribute of biopharmaceuticals which can affect drug clearance, potency and safety as well as productivity. All these aspects are addressed by FyoniBio´s human GlycoExpress cells as well as the CHO platform technology CHOnamite coupled with upstream and downstream process optimization, state-of-the-art equipment and in-house developed software for glycan analytics. The service portfolio is complemented by GCLP-compliant bioanalysis of clinical samples including pharmacokinetics, genotyping, biomarker and immunogenicity assessment.

FyoniBio revenue & valuation

Annual revenue	$2,053,320
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$6,600,000
Total funding	No funding

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Director

C-Suite

Employees by Department

FyoniBio has 10 employees across 6 departments.

Departments

Number of employees

Funding Data

FyoniBio has never raised funding before.

FyoniBio Tech Stack

Discover the technologies and tools that power FyoniBio's digital infrastructure, from frameworks to analytics platforms.

MySQL

Databases

WordPress

Blogs

Nginx

Reverse proxies

PHP

Programming languages

Frequently asked questions

FyoniBio is located in Berlin, Berlin, DE.

You can reach FyoniBio at +493094892500.

FyoniBio was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

FyoniBio has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.